Fidelity International’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-250
Closed -$35K – 833
2021
Q4
$35K Hold
250
– – ﹤0.01% 797
2021
Q3
$33K Hold
250
– – ﹤0.01% 808
2021
Q2
$34K Hold
250
– – ﹤0.01% 840
2021
Q1
$33K Hold
250
– – ﹤0.01% 823
2020
Q4
$28K Buy
250
+130
+108% +$12.3K ﹤0.01% 776
2020
Q3
$9K Buy
+120
New +$9.79K ﹤0.01% 752

Other funds holding CNMD

Fidelity International's CNMD Position: Q1 2022 in Review

Fidelity International sold out of CONMED (CNMD) in Q1 2022, closing a stake of 250 shares — an estimated $35K sold.

Fidelity International first reported a position in CNMD in Q3 2020 and held it in 6 quarters. The position peaked at $35K in Q4 2021. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2022.

  • Fidelity International reported no remaining CONMED position as of Q1 2022 after selling out during the quarter.
  • Fidelity International sold 250 CONMED shares in Q1 2022, an estimated $35K.
  • Fidelity International first reported a position in CONMED in Q3 2020 and held it in 6 quarters.
  • Fidelity International's CONMED position peaked at $35K in Q4 2021.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2022.

Based on Fidelity International's 13F filing for Q1 2022, filed 13 May 2022.